Organic Acid Profile: Which Tests to Pair It With

A urine organic acids test (OAT), sometimes sold commercially as a comprehensive organic acids profile (Genova Diagnostics is one of several labs offering this format), measures dozens of metabolic intermediates by gas chromatography-mass spectrometry from a single urine specimen. It is a laboratory-developed screening tool, not a genetic test and not the same as a newborn screening dried blood spot panel or a targeted blood organic acid assay. It cannot confirm a diagnosis by itself.

A urine organic acids test cannot be safely interpreted in isolation. Because the metabolites it detects overlap across genetic, nutritional, dietary, and medication-related causes, a clinically useful workup pairs it with plasma amino acids, an acylcarnitine profile, serum methylmalonic acid, and homocysteine, ideally drawn within the same fasting window. Professional genetics society guidance treats these panels as complementary rather than interchangeable when evaluating suspected inborn errors of metabolism. A single elevated organic acid, without a corroborating pattern on these companion tests, is a hypothesis rather than a diagnosis.

The useful question for a reader looking at an abnormal OAT result is not "is this marker high," but "does the companion blood testing corroborate this specific pattern before anyone changes treatment." That distinction is where most of the clinical value, and most of the risk of overreaching, actually sits.

What a urine organic acids test actually measures

Organic acids are water-soluble intermediates generated during amino acid catabolism, fatty acid oxidation, carbohydrate metabolism, and neurotransmitter turnover. A single OAT run can flag many analytes at once, and that breadth is both its strength and its limitation. An elevated adipic acid result, for example, could reflect a fatty acid oxidation defect, a period of prolonged fasting, or simply a high-fat meal eaten the night before collection. Without confirmatory data from blood-based assays, an abnormal organic acid result stays a hypothesis.

Specimen handling affects the result directly. Bacterial overgrowth in an unpreserved sample can generate artifactual peaks, particularly D-lactic acid and phenylacetic acid, that mimic metabolic disease. Freezing the sample promptly, shipping on dry ice, and documenting recent antibiotic or antifungal use are standard steps to reduce this risk standard laboratory handling guidance.

The core companion panel: plasma amino acids

Plasma amino acids are the single most useful add-on. Organic acids reflect downstream metabolites; amino acids reflect the upstream substrates. Read together, the two can triangulate a pathway. If 3-methylglutaconic acid is elevated on OAT but leucine and isoleucine are normal on a fasting amino acid panel, a branched-chain amino acid oxidation defect becomes less likely and a mitochondrial membrane issue moves up the differential Wortmann et al., 3-methylglutaconic aciduria.

Timing matters. Both specimens should ideally be collected in the same fasting state, close together in time, because a fed-state amino acid panel introduces postprandial noise, particularly elevated branched-chain amino acids, that can confound interpretation. Fasting protocols and reference age cutoffs for plasma amino acids are addressed in professional genetics practice guidance. Reference intervals also shift with age; neonates normally show higher glycine and proline concentrations than adults, and older studies of adult plasma amino acid distributions provide useful but lab-dependent context rather than a universal number older studies of adult plasma amino acid distributions.

Acylcarnitine profile: the fatty acid oxidation checkpoint

The acylcarnitine profile, drawn from a dried blood spot or plasma, evaluates carnitine-conjugated intermediates of fatty acid beta-oxidation and select amino acid pathways. Reviews of fatty acid oxidation disorders describe acylcarnitine analysis as complementary to organic acid testing for improving diagnostic yield in this category reviews of fatty acid oxidation disorders. A specific percentage improvement in sensitivity from combining the two tests is sometimes cited in secondary sources, but that number could not be verified against the primary literature for this page and should be treated as unconfirmed rather than repeated as a fact.

Ordering an acylcarnitine profile is reasonable whenever OAT shows elevated suberic acid, sebacic acid, or medium-chain dicarboxylic acids, because these findings suggest impaired beta-oxidation but cannot by themselves distinguish medium-chain acyl-CoA dehydrogenase deficiency (MCADD) from long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). MCADD is described as the most common fatty acid oxidation disorder in populations of Northern European descent, with population-genetic studies estimating a birth prevalence on the order of roughly 1 in tens of thousands, though the exact figure varies by cohort and should be confirmed against a current population-genetics source before it is quoted precisely population-genetic studies of fatty acid oxidation disorders.

Free and total carnitine should be included with the acylcarnitine order. A low free carnitine result alongside elevated acylcarnitines points toward secondary carnitine depletion, which changes supplementation decisions on its own.

Do not start pharmacologic-dose carnitine supplementation in a patient with a suspected but unconfirmed long-chain fatty acid oxidation defect. In disorders such as VLCADD, excess carnitine loading can generate toxic long-chain acylcarnitines rather than a benefit, which is one reason genetic or enzymatic confirmation should precede aggressive supplementation.

Methylmalonic acid and homocysteine: the B12-folate axis

Methylmalonic acid (MMA) in serum confirms what an elevated urine methylmalonate on OAT only suggests. Serum MMA distinguishes a true B12-dependent block from renal concentrating effects or mild dehydration artifacts that can raise urine methylmalonate without reflecting a real deficiency Stabler, clinical review of B12 deficiency.

Decision framework: which companion test actually changes what you do

Two exceptions override this stepwise approach. First, an acutely ill patient, especially an infant with poor feeding, vomiting, lethargy, or altered mental status alongside an abnormal metabolic panel, needs emergency evaluation rather than a scheduled outpatient companion-test workup. Second, do not treat empirically (high-dose carnitine, aggressive dietary restriction, or antifungal therapy) based on OAT alone; confirm with the relevant companion test first, because some corrective actions carry their own risk when the underlying diagnosis turns out to be different from what OAT suggested.

Homocysteine fills out the B12-folate picture. Both B12 and folate feed the methionine synthase reaction, so an elevated homocysteine with a normal MMA points toward isolated folate depletion, while both elevated points toward B12 deficiency or a combined deficiency. A systematic review of MMA and homocysteine as B-vitamin status biomarkers reports that using both markers together improves correct classification of the deficient vitamin compared with relying on serum B12 alone, though the exact percentages sometimes cited for this comparison were not independently verified for this page and should be confirmed against the primary review before being quoted as precise figures a review of MMA and homocysteine as B-vitamin status biomarkers.

Stabler's widely cited clinical review of B12 deficiency makes a point that is central to why this pairing matters: serum B12 concentrations can appear normal in patients who have genuine tissue-level deficiency, which is why metabolic markers such as MMA and homocysteine carry more diagnostic weight than a B12 level checked in isolation Stabler, vitamin B12 deficiency, New England Journal of Medicine.

Comprehensive metabolic panel and CBC

A comprehensive metabolic panel (CMP) is baseline infrastructure for interpreting OAT. It contextualizes findings in three ways. Renal function matters because impaired clearance alters organic acid concentrations and can make results unreliable without proper normalization to urine creatinine. Liver transaminases matter because elevated AST and ALT alongside elevated TCA-cycle intermediates raise suspicion for a mitochondrial hepatopathy rather than a primary cycle defect. Glucose and bicarbonate matter because a low bicarbonate with a high anion gap, combined with elevated lactate on OAT, is a signal for urgent or emergency evaluation rather than an outpatient workup.

A complete blood count adds one more data point. Macrocytic anemia (an elevated mean corpuscular volume) is consistent with the functional B12 or folate deficiency suggested by elevated MMA or FIGLU on OAT, and neutrophil hypersegmentation on a peripheral smear is an earlier finding in the same process clinical reviews of vitamin B12 deficiency hematologic findings.

Nutrient cofactor levels: B2, B6, and CoQ10

OAT markers of cofactor status are indirect. Elevated glutaric acid and 2-hydroxyglutaric acid can reflect riboflavin (B2) deficiency, but they also appear in glutaric acidemia type I, a rare genetic condition that is biochemically distinct from simple deficiency and requires its own confirmation. To differentiate the two, erythrocyte glutathione reductase activity coefficient (EGRAC) is used as a functional marker of riboflavin status Powers, riboflavin and health. A precise population prevalence for glutaric acidemia type I is not supported by the source used here and should not be quoted as a fixed number without checking a dedicated epidemiology source.

Pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, is worth measuring when OAT shows elevated xanthurenic or kynurenic acid, since these tryptophan catabolites accumulate when B6-dependent kynureninase activity is impaired. There is no formal medical-society guideline threshold for PLP testing in this context; the Linus Pauling Institute's background review on vitamin B6 discusses commonly used insufficiency cutoffs for non-pregnant adults, and clinicians should treat this as institutional background rather than a binding guideline background reviews of vitamin B6 status assessment.

Coenzyme Q10 (ubiquinone) is sometimes checked when OAT shows an elevated succinate-to-fumarate ratio, particularly in patients with myopathy or exercise intolerance. Specific serum cutoffs for "low" CoQ10 vary by laboratory, and no primary source for a precise cutoff was available for this page; treat any specific numeric threshold your lab reports as lab-specific rather than a universal clinical standard.

Lactate, pyruvate, and the lactate-to-pyruvate ratio

Elevated urine lactate on OAT should prompt a properly collected venous blood lactate. Distinguishing a collection artifact from genuine lactic acidosis depends on a free-flowing venous draw processed quickly, since delayed processing falsely raises lactate.

The lactate-to-pyruvate (L:P) ratio helps classify the mechanism once true elevation is confirmed. A high L:P ratio is associated with impaired oxidative phosphorylation (a respiratory chain defect), while a lower L:P ratio with elevated lactate points toward pyruvate dehydrogenase deficiency or a gluconeogenic disorder; the diagnostic accuracy of this ratio in congenital lactic acidosis has been formally studied Debray et al., diagnostic accuracy of the lactate-to-pyruvate ratio. DiMauro and Schon's landmark review of mitochondrial respiratory-chain disease describes the L:P ratio as one of the simplest bedside tools available for separating mitochondrial from non-mitochondrial causes of lactic acidosis reviews of mitochondrial respiratory-chain disease.

Pyruvate is notoriously unstable as a specimen. It should be collected in a perchloric acid tube, kept on ice, and delivered promptly, since any delay invalidates the ratio and can produce a falsely abnormal result.

Genetic confirmation: when to escalate

An abnormal OAT finding that persists on repeat testing, is corroborated by the paired blood panels described above, and does not resolve with cofactor supplementation is a reasonable trigger for genetic testing. Broader overviews of inborn errors of metabolism describe genetic confirmation as the appropriate next step before committing a patient to long-term dietary restriction or high-dose cofactor supplementation Saudubray & Garcia-Cazorla, overview of inborn errors of metabolism. Specific figures for what proportion of OAT-flagged children go on to receive a confirmed genetic diagnosis, versus a transient or dietary explanation, vary across the studies that report them and were not verified against a specific dataset for this page; treat any single percentage you encounter elsewhere as illustrative of a real phenomenon (many OAT flags turn out benign) rather than a number to apply to an individual patient.

Targeted multi-gene panels covering inborn errors of metabolism are available from several commercial labs, and the specific genes covered and panel size change over time as labs update their offerings, so a gene count quoted today may be out of date by the time a reader checks it. Confirm current panel contents directly with the testing lab rather than relying on a fixed number.

How to interpret reference ranges

There is no single "normal organic acids level," because the test reports many analytes, each with its own reference interval, typically expressed per mole of urine creatinine to account for concentration differences. Specific numeric reference ranges (for example, for methylmalonate or suberic acid) differ by laboratory and by panel version, and a general methods reference on organic acid analysis is not the right source to cite for a specific commercial lab's current published ranges general laboratory methods references. Readers should check the reference range printed on their own lab report rather than a range quoted from a secondary source, since these can change between panel versions.

Age, diet, medication, and hydration status all shift individual analyte concentrations, which is why a single "high" marker is rarely actionable by itself. Multiple elevated markers within the same metabolic pathway, especially when corroborated across OAT, amino acids, and acylcarnitines, carry more diagnostic weight than one outlier value.

Collection protocol and pre-analytic variables

A first morning void is generally preferred for spot collections, with a fasting period beforehand (water permitted) and biotin supplements discontinued for at least several days before collection, since biotin-dependent carboxylase substrates are directly affected by recent biotin intake.

Several medications are known to alter OAT results, including valproic acid (elevated 3-hydroxy-3-methylglutaric acid), aspirin (elevated 2-hydroxyhippuric acid), and acetaminophen (a 5-oxoproline peak that can mimic a glutathione synthesis defect) clinical reviews of medication effects on urine organic acid results. Document all supplements and prescriptions on the requisition form.

Arabinose and tartaric acid elevations are sometimes attributed to intestinal yeast overgrowth in functional-medicine contexts, but a critical appraisal published in Clinical Chemistry concluded there is insufficient evidence to support urine D-arabinitol as a standalone marker for invasive candidiasis a critical appraisal of D-arabinitol as a candiduria marker. If fungal overgrowth is a genuine clinical concern, a stool-based comprehensive panel or serum beta-D-glucan is a more direct test than relying on this OAT marker alone.

What is established, what is plausible, and what is not established

Established: OAT is a recognized first-tier tool in the evaluation of suspected inborn errors of metabolism, and interpreting it alongside plasma amino acids and an acylcarnitine profile is standard practice in that setting according to ACMG guidance. Serum MMA and homocysteine, used together, are a well-supported way to distinguish B12- from folate-driven biochemical abnormalities. The lactate-to-pyruvate ratio, when the specimen is collected correctly, is an established tool for classifying causes of lactic acidosis.

Plausible but not tightly quantified from the sources reviewed here: the magnitude of diagnostic-yield improvement from combining OAT with acylcarnitine testing, the exact proportion of OAT-flagged patients who ultimately receive a confirmed genetic diagnosis, and precise numeric cutoffs for CoQ10 and some other cofactor markers. These directions are reasonable but the specific numbers circulating in secondary sources should be verified against primary literature before being treated as settled facts.

Not established: using isolated OAT markers such as arabinose, tartaric acid, or hippuric acid as a standalone basis for diagnosing intestinal dysbiosis, chronic fatigue, or mitochondrial dysfunction is not supported by the evidence summarized on this page and should not drive treatment decisions without corroborating, more direct testing.